These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21606745)

  • 1. Characteristics of women in the United States who use long-acting reversible contraceptive methods.
    Kavanaugh ML; Jerman J; Hubacher D; Kost K; Finer LB
    Obstet Gynecol; 2011 Jun; 117(6):1349-1357. PubMed ID: 21606745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009-2012.
    Kavanaugh ML; Jerman J; Finer LB
    Obstet Gynecol; 2015 Nov; 126(5):917-927. PubMed ID: 26444110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project.
    Allsworth JE; Secura GM; Ajibade OO; Peipert JF
    J Womens Health (Larchmt); 2018 May; 27(5):599-606. PubMed ID: 29768114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with postpartum use of long-acting reversible contraception.
    Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
    Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.
    Secura GM; Allsworth JE; Madden T; Mullersman JL; Peipert JF
    Am J Obstet Gynecol; 2010 Aug; 203(2):115.e1-7. PubMed ID: 20541171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
    Ihongbe TO; Masho SW
    J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher uptake of long-acting reversible and permanent methods of contraception by Australian women living in rural and remote areas.
    Lucke JC; Herbert DL
    Aust N Z J Public Health; 2014 Apr; 38(2):112-6. PubMed ID: 24690048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices.
    Lam VC; Hadley EE; Berenson AB; Hirth JM; Jennings K; Patel PR
    J Reprod Med; 2016; 61(11-12):529-33. PubMed ID: 30226692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraceptive continuation in Hispanic women.
    Werth SR; Secura GM; Broughton HO; Jones ME; Dickey V; Peipert JF
    Am J Obstet Gynecol; 2015 Mar; 212(3):312.e1-8. PubMed ID: 25218956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010.
    Moreau C; Bohet A; Hassoun D; Teboul M; Bajos N;
    Fertil Steril; 2013 Aug; 100(2):451-8. PubMed ID: 23663994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting reversible contraception: reducing unintended pregnancies.
    Ruddick C
    Community Pract; 2009 Sep; 82(9):24-7. PubMed ID: 19788120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
    Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
    Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with long-acting and short-acting reversible contraceptive use in Ethiopia: an analysis of the 2016 Demographic and Health Survey.
    Stonehill A; Bishu SG; Taddese HB
    Eur J Contracept Reprod Health Care; 2020 Oct; 25(5):350-358. PubMed ID: 32677852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in long-acting reversible contraception use among U.S. women aged 15-44.
    Branum AM; Jones J
    NCHS Data Brief; 2015 Feb; (188):1-8. PubMed ID: 25714042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of unintended pregnancy: a focus on long-acting reversible contraception.
    Pickle S; Wu J; Burbank-Schmitt E
    Prim Care; 2014 Jun; 41(2):239-60. PubMed ID: 24830607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing Patterns of Contraceptive Use and the Decline in Rates of Pregnancy and Birth Among U.S. Adolescents, 2007-2014.
    Lindberg LD; Santelli JS; Desai S
    J Adolesc Health; 2018 Aug; 63(2):253-256. PubMed ID: 30149926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States.
    Xu X; Macaluso M; Frost J; Anderson JE; Curtis K; Grosse SD
    Fertil Steril; 2011 Nov; 96(5):1138-44. PubMed ID: 21917255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.